NUTEX HEALTH INC (NUTX) — insider trading
Health Care · NASDAQ
NUTEX HEALTH INC (NUTX) has 21 reported SEC Form 4 insider transactions in our data, including 4 open-market purchases and 1 open-market sale among the most recent 21 (latest 2026-09-18).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-18 | Saunders Scott J | Director | Open-market sale | 203 | $214.25 | $43.5K | Form 4 |
| 2026-07-31 | Reed Michael Lee | Director | Option exercise / conversion | 603 | — | $0 | Form 4 |
| 2026-07-31 | Saunders Scott J | Director | Option exercise / conversion | 603 | — | $0 | Form 4 |
| 2026-07-31 | Grenas Cheryl Yvonne | Director | Option exercise / conversion | 603 | — | $0 | Form 4 |
| 2026-07-31 | Jaumot Frank E | Director | Option exercise / conversion | 603 | — | $0 | Form 4 |
| 2026-06-04 | Spears Kelvin | Director | Other acquisition or disposition | 2,519 | — | $0 | Form 4 |
| 2026-05-28 | Vo Thomas T. | Director, Officer (Chief Executive Officer) | Other acquisition or disposition | 75,747 | — | $0 | Form 4 |
| 2026-04-23 | Grenas Cheryl Yvonne | Director | Grant / award / vesting (derivative) | 823 | — | $0 | Form 4 |
| 2026-04-23 | Jaumot Frank E | Director | Grant / award / vesting (derivative) | 823 | — | $0 | Form 4 |
| 2026-04-23 | Saunders Scott J | Director | Grant / award / vesting (derivative) | 823 | — | $0 | Form 4 |
| 2026-04-23 | Reed Michael Lee | Director | Grant / award / vesting (derivative) | 823 | — | $0 | Form 4 |
| 2026-04-09 | Vo Thomas T. | Director, Officer (Chief Executive Officer) | Other acquisition or disposition | 184,071 | — | $0 | Form 4 |
| 2026-03-20 | Jaumot Frank E | Director | Open-market purchase | 150 | $93.56 | $14.0K | Form 4 |
| 2026-03-19 | Hosseinion Warren | Director, Officer (President) | Open-market purchase | 252 | $94.07 | $23.7K | Form 4 |
| 2026-03-17 | Spears Kelvin | Director | Open-market purchase | 10 | $94.46 | $945 | Form 4 |
| 2026-03-13 | Montgomery Pamela W. | Officer (Chief Legal Officer-Healthcare) | Open-market purchase | 79 | $88.87 | $7.0K | Form 4 |
| 2026-03-11 | Bamburg Wesley Shane | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 2,411 | — | $0 | Form 4 |
| 2026-03-10 | Vo Thomas T. | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 4,841 | — | $0 | Form 4 |
| 2026-03-10 | Hosseinion Warren | Director, Officer (President) | Option exercise / conversion (derivative) | 3,656 | — | $0 | Form 4 |
| 2026-03-10 | Spears Kelvin | Director | Option exercise / conversion (derivative) | 116 | — | $0 | Form 4 |
| 2026-03-10 | Montgomery Pamela W. | Officer (Chief Legal Officer-Healthcare) | Option exercise / conversion (derivative) | 1,523 | — | $0 | Form 4 |
Ask the chat about NUTX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: NUTEX HEALTH INC (NUTX).
Last updated 2026-09-18 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.